Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.62 HKD | -1.73% | -4.35% | -2.01% |
Mar. 22 | Shanghai Henlius Biotech Turns to Profit in 2023 | MT |
Mar. 21 | Shanghai Henlius Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2023 | 5.39B 747M 5.84B | Sales 2024 * | 5.89B 816M 6.38B | Capitalization | 6.96B 963M 7.53B |
---|---|---|---|---|---|
Net income 2023 | 546M 75.56M 591M | Net income 2024 * | 600M 83.04M 650M | EV / Sales 2023 | 1.27 x |
Net cash position 2023 * | - 0 0 | Net cash position 2024 * | - 0 0 | EV / Sales 2024 * | 1.18 x |
P/E ratio 2023 |
12.6
x | P/E ratio 2024 * |
11.7
x | Employees | 3,637 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 21.57% |
1 day | -1.73% | ||
1 week | -4.35% | ||
Current month | +1.49% | ||
1 month | +3.18% | ||
3 months | -1.30% | ||
6 months | +26.11% | ||
Current year | -2.01% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Dong Jiang
FOU | Founder | - | 09-11-30 |
Jun Zhu
CEO | Chief Executive Officer | 46 | 21-11-29 |
Wei Huang
PSD | President | 56 | 20-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Qi Yu Chen
BRD | Director/Board Member | 51 | 13-01-14 |
Tak Young So
BRD | Director/Board Member | 54 | 19-09-01 |
Xiao Hui Guan
BRD | Director/Board Member | 53 | 18-12-23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 2 M€ | -.--% | ||
0.01% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 13.62 | -1.73% | 176 641 |
24-03-27 | 13.86 | -0.72% | 112,200 |
24-03-26 | 13.96 | +0.43% | 105,500 |
24-03-25 | 13.9 | -1.84% | 167,100 |
24-03-22 | 14.16 | -0.56% | 211,204 |
Delayed Quote Hong Kong S.E., March 28, 2024 at 04:08 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.01% | 963M | |
+0.44% | 90.27B | |
+10.00% | 44.05B | |
-16.40% | 31.45B | |
+44.42% | 23.35B | |
-8.10% | 16.72B | |
-25.64% | 15.09B | |
-9.03% | 12.82B | |
-9.37% | 11.95B | |
+98.58% | 7.67B |